Clin2
NCT07087379Possibly a fitNot yet recruiting

Intensive statin therapy to protect the brain during TAVR

Aortic StenosisCerebral Ischaemic Injury

Part of Heart & circulation clinical trials.

This trial tests whether giving a high dose of a statin (atorvastatin) before and during a heart valve replacement procedure (TAVR) can reduce the risk of brain injury. Statins are cholesterol-lowering drugs that may also protect the brain, and this study aims to see if they help people undergoing TAVR.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
500 people
Ages
65 years to 80 years
Study type
Interventional

Who can take part

  • You are between 65 and 80 years old.
  • You have severe narrowing of your aortic heart valve (aortic stenosis) and are scheduled for a TAVR procedure.
  • You have not taken any statin medication in the past month.
  • You have no major memory or thinking problems (Montreal Cognitive Assessment score above 20).
  • You can have an MRI scan and do not have a permanent pacemaker or severe claustrophobia.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06007222Recruiting· Phase 4
No blood thinners after TAVI: a trial for heart valve patients

This trial is for people who have had a TAVI procedure to replace a narrowed heart valve, and it tests whether it is safe to skip blood thinners afterward. The goal is to find the best way to protect your health without unnecessary medication.

Shinjuku, Tokyo
NCT06472934Recruiting
Beta-blockers & TAVR study

This study tests whether continuing a beta-blocker (a heart medication) improves outcomes for people having a planned TAVR (a minimally invasive heart-valve replacement). It may help doctors decide whether to keep or stop this medicine after the procedure.

Graz
NCT07276711Recruiting
Protecting brain during TAVR with EmStop device

This trial tests a new device (EmStop) that helps protect your brain during TAVR (a type of heart valve replacement). The device is placed in arteries to catch any debris that might break loose during the procedure, potentially reducing the risk of stroke.

Thousand Oaks, California
NCT07045233Enrolling by invitation
Using a brain protection device during TAVR to prevent stroke

This study tests if a special device placed during transcatheter aortic valve replacement (TAVR) can help prevent stroke. It is for adults with severe aortic stenosis who are already scheduled for TAVR.

Beijing
NCT05912686Not yet recruiting· Phase 4
High-dose atorvastatin to protect vessel walls after thrombectomy

This trial tests whether high-dose atorvastatin can help protect the artery wall after emergency clot-removal treatment for an acute stroke. It uses a special 3T MRI scan to look for changes in the blood vessels and may lower the risk of future problems if the artery wall is better protected.

Nanjing, Jiangsu
NCT05076019Recruiting
Atorvastatin during heart valve surgery for patients over 60

This trial studies whether taking atorvastatin (a cholesterol medicine) around the time of surgical aortic valve replacement can improve outcomes. It is mainly for people who have not taken similar medicines recently and do not have certain heart rhythm or liver/kidney problems.

Odense

Hear when a new Aortic Stenosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.